CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2023	Jun. 30, 2023
Current assets:
Cash	$ 384,735	$ 625,964
Prepaid expenses	3,394	16,785
Deposits and other assets	6,000	6,000
Total current assets	394,129	648,749
Operating lease right-of-use asset	66,090	93,875
Property and equipment, net (Note 3)	9,110,640	6,851,009
Total assets	9,570,859	7,593,633
Current liabilities:
Accounts payable and accrued expenses	2,648,005	677,136
Deferred compensation (Note 4)	1,225,226	864,781
Convertible Bridge Note Payable (Note 6)	255,407
Operating lease liability, current (Note 9)	71,091	75,000
Total current liabilities	4,199,729	1,616,917
Operating lease liability, long term (Note 9)		29,068
Convertible notes payable - affiliates (Note 6)	1,740,083	1,715,970
Total liabilities	5,939,812	3,361,955
Equity (deficit):
Common stock, no par value, 250,000,000 shares authorized, 50,611,962  and 48,044,790 shares issued, respectively; 49,907,653 and 47,340,480 shares outstanding, respectively
Additional paid-in capital	132,798,923	131,935,418
Subscription receivable - affiliates (Note 8)	(504,650)	(504,650)
Accumulated deficit	(128,700,799)	(127,236,663)
Total Bion's stockholders’ equity (deficit)	3,593,474	4,194,105
Noncontrolling interest	37,573	37,573
Total equity (deficit)	3,631,047	4,231,678
Total liabilities and deficit	$ 9,570,859	$ 7,593,633